SEI Investments
INFI

SEI Investments’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

SEI Investments’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-21,560
Closed -$114K – 2790
2016
Q1 		$114K Hold
21,560
– – ﹤0.01% 1643
2015
Q4 		$169K Sell
21,560
-40,597
-65% -$349K ﹤0.01% 1592
2015
Q3 		$525K Buy
62,157
+16,229
+35% +$150K ﹤0.01% 1276
2015
Q2 		$503K Buy
45,928
+1,306
+3% +$16.8K ﹤0.01% 1175
2015
Q1 		$624K Buy
+44,622
New +$682K 0.01% 1120

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SEI Investments's INFI Position: Q2 2016 in Review

SEI Investments sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2016, closing a stake of 21,560 shares — an estimated $114K sold.

SEI Investments first reported a position in INFI in Q1 2015 and held it in 5 quarters. The position peaked at $624K in Q1 2015. 107 funds tracked by Wall St. Rank hold INFI as of Q2 2016.

  • SEI Investments reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • SEI Investments sold 21,560 Infinity Pharmaceuticals, Inc. shares in Q2 2016, an estimated $114K.
  • SEI Investments first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2015 and held it in 5 quarters.
  • SEI Investments's Infinity Pharmaceuticals, Inc. position peaked at $624K in Q1 2015.
  • 107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2016.

Based on SEI Investments's 13F filing for Q2 2016, filed 11 Aug 2016.